Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Forbes contributors publish independent expert analyses and insights. Rachel Wells is a writer who covers leadership, AI, and upskilling. If you've been out of the job search game for a while and only ...

Whether you’re making small talk less awkward or trying to figure out if there's something you still don't know about your long-time besties, there’s one game that never fails to deliver - Never Have ...

No matter how long you've been in a relationship, there's always room to grow. In fact, continually being curious about your partner can help strengthen your bond, especially since people change over ...

Whether you love or hate them, sports are a defining part of our collective culture. Each one has so many little bits and bobs of information that extend across history, math, pop culture and more.